Related Experiment Videos
Platelet monoamine oxidase activity in schizophrenic families - kinetic aspects
Abstract:
Monoamine oxidase activity (MAO) was determined in platelets in samples from a North-Swedish pedigree with a high frequency of schizophrenia. The MAO assay was performed with phenethylamine as substrate and with two concentrations of oxygen (0.06 and 0.12 mM). A tendency to lowered Vmax and increased apparent Km values was observed among the schizophrenic subjects, although there were no statistically significant differences in apparent Km and Vmax values between schizophrenics and their non-schizophrenic relatives.
Insights
Monoamine oxidase (MAO) activity in platelets showed a trend toward lower Vmax and higher Km in schizophrenic individuals from a Swedish family. However, these differences were not statistically significant compared to non-schizophrenic relatives.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Schizophrenia is a complex psychiatric disorder with a suspected genetic component.
- Monoamine oxidase (MAO) enzymes play a crucial role in neurotransmitter metabolism and have been implicated in various psychiatric conditions.
- Platelet MAO activity has been studied as a potential biomarker in schizophrenia.
Purpose of the Study:
- To investigate monoamine oxidase (MAO) activity in platelets of individuals from a North-Swedish pedigree with a high prevalence of schizophrenia.
- To determine if altered MAO kinetics (Vmax and Km) are associated with schizophrenia in this familial cohort.
Main Methods:
- MAO activity was measured in platelet samples using phenethylamine as a substrate.
- Enzyme kinetics were analyzed at two different oxygen concentrations (0.06 and 0.12 mM).
- Kinetic parameters, including Vmax (maximum velocity) and apparent Km (Michaelis-Menten constant), were calculated for schizophrenic subjects and their non-schizophrenic relatives.
Main Results:
- A trend towards lower Vmax and increased apparent Km values for MAO activity was observed in schizophrenic subjects compared to their relatives.
- No statistically significant differences in Vmax or apparent Km were found between the schizophrenic and non-schizophrenic groups within the studied pedigree.
- The findings suggest potential, but not conclusive, alterations in MAO enzyme kinetics in schizophrenia.
Conclusions:
- While a trend was observed, this study did not find statistically significant differences in platelet MAO kinetics between schizophrenic patients and their relatives in this North-Swedish pedigree.
- Further research with larger sample sizes or different methodologies may be needed to clarify the role of MAO activity in schizophrenia pathogenesis.
- Platelet MAO activity may not serve as a definitive diagnostic biomarker for schizophrenia in all populations or familial contexts.